Skip to main content

Top Biotech Picks: “The Strong Will Survive And Thrive”

After two volatile years, the biotech sector still faces rough times ahead with tough competition, push back from insurers and slowing volumes. But taking a line from Charles Darwin , analysts at Jefferies argue that ‘the strong will survive and thrive.” And just who are “the strong?” Jefferies’ top picks for 2017 include Celgene ( CELG ), Gilead Sciences ( GILD ), Alkermes ( ALKS ) and Vertex ( VRTX ).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.